English

GALERA THERAPEUTICS, INC.

EDGAR

GRTX Quarterly report (10-Q) · filed 2026-05-14

34 filing records in this dataset, filed from 2019-10-11 to 2026-05-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 5.5 million USD 2026-03-31 Source
Exact value

5500000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 75.5 million shares 2026-03-31 Source
Exact value

75462390 shares

Reported share-count change

0.00% · 0 shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

75462390 shares · 2025-03-31· Source
75462390 shares · 2026-03-31· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

149 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence

Net income: -1075000 USD · 2025-04-01 – 2025-06-30 Source
Net income: -1388000 USD · 2025-07-01 – 2025-09-30 Source
Net income: 149049000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -4055000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -1606000 USD · 2026-01-01 – 2026-03-31 Source

Operating cash flow

-4.69 million USD

2025-04-01 – 2026-03-31

Exact inputs and evidence

Operating cash flow: -3694000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -2238000 USD · 2025-01-01 – 2025-03-31 Source
Operating cash flow: -4451000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -3694000 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -6049000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -4451000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -875000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-05-14.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 8 of 11 periods available· newest 2025-12-31
Net income: 8 of 11 periods available· newest 2025-12-31
Operating cash flow: 8 of 11 periods available· newest 2025-12-31
Capital expenditure: 7 of 11 periods available· newest 2024-12-31
Total assets: 8 of 11 periods available· newest 2025-12-31
Total liabilities: 8 of 11 periods available· newest 2025-12-31
Current assets: 8 of 11 periods available· newest 2025-12-31
Current liabilities: 8 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 8 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 8 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 168.01 million

Prior period

−USD 18.96 million

2024-01-01 – 2024-12-31
Current period

USD 149.05 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

149049000 − -18957000 = 168006000 USD

-18957000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
149049000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GALERA THERAPEUTICS, INC. · 2025-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Year-over-year change in Net income: 168006000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 149049000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156357726000005/grtx-20251231.htm#1486317 Filing: 000156357726000005 Input fundies:NetIncome: -18957000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156357726000005/grtx-20251231.htm#1488169 Filing: 000156357726000005
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 6.1 million

Prior period

−USD 12.15 million

2024-01-01 – 2024-12-31
Current period

−USD 6.05 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-6049000 − -12145000 = 6096000 USD

-12145000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-6049000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GALERA THERAPEUTICS, INC. · 2025-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Year-over-year change in Operating cash flow: 6096000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -6049000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156357726000005/grtx-20251231.htm#1325911 Filing: 000156357726000005 Input fundies:OperatingCashFlow: -12145000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156357726000005/grtx-20251231.htm#1327794 Filing: 000156357726000005
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2018 2018-01-01 – 2018-12-31	−USD 23.68 million Exact value Exact value: -23676000 USD 2018-01-01 – 2018-12-31: -23676000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GALERA THERAPEUTICS, INC. · 2018-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Net Income: -23676000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23676000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459020009542/grtx-20191231.xml#87766 Filing: 000156459020009542 The citation records this snapshot. The page link may show a newer release later.	−USD 22.17 million Exact value Exact value: -22166000 USD 2018-01-01 – 2018-12-31: -22166000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GALERA THERAPEUTICS, INC. · 2018-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Operating Cash Flow: -22166000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22166000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459020009542/grtx-20191231.xml#108065 Filing: 000156459020009542 The citation records this snapshot. The page link may show a newer release later.	USD 347,000 Exact value Exact value: 347000 USD 2018-01-01 – 2018-12-31: 347000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GALERA THERAPEUTICS, INC. · 2018-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Capital Expenditure: 347000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 347000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459020009542/grtx-20191231.xml#109295 Filing: 000156459020009542 The citation records this snapshot. The page link may show a newer release later.	−USD 22.51 million Calculation and evidence -22166000 − 347000 USD Exact free cash flow: -22513000 USD 2018-01-01 – 2018-12-31: -22166000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 347000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GALERA THERAPEUTICS, INC. · 2018-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Free cash flow: -22513000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -22166000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459020009542/grtx-20191231.xml#108065 Filing: 000156459020009542 Input fundies:CapitalExpenditure: 347000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459020009542/grtx-20191231.xml#109295 Filing: 000156459020009542 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 51.93 million Exact value Exact value: -51930000 USD 2019-01-01 – 2019-12-31: -51930000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GALERA THERAPEUTICS, INC. · 2019-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Net Income: -51930000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -51930000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459021012244/grtx-10k_20201231.htm#1917146 Filing: 000156459021012244 The citation records this snapshot. The page link may show a newer release later.	−USD 46.66 million Exact value Exact value: -46661000 USD 2019-01-01 – 2019-12-31: -46661000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GALERA THERAPEUTICS, INC. · 2019-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Operating Cash Flow: -46661000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -46661000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459021012244/grtx-10k_20201231.htm#2087963 Filing: 000156459021012244 The citation records this snapshot. The page link may show a newer release later.	USD 633,000 Exact value Exact value: 633000 USD 2019-01-01 – 2019-12-31: 633000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GALERA THERAPEUTICS, INC. · 2019-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Capital Expenditure: 633000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 633000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459021012244/grtx-10k_20201231.htm#2103752 Filing: 000156459021012244 The citation records this snapshot. The page link may show a newer release later.	−USD 47.29 million Calculation and evidence -46661000 − 633000 USD Exact free cash flow: -47294000 USD 2019-01-01 – 2019-12-31: -46661000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 633000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GALERA THERAPEUTICS, INC. · 2019-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Free cash flow: -47294000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -46661000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459021012244/grtx-10k_20201231.htm#2087963 Filing: 000156459021012244 Input fundies:CapitalExpenditure: 633000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156459021012244/grtx-10k_20201231.htm#2103752 Filing: 000156459021012244 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 74.22 million Exact value Exact value: -74218000 USD 2020-01-01 – 2020-12-31: -74218000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GALERA THERAPEUTICS, INC. · 2020-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Net Income: -74218000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -74218000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017022003292/grtx-20211231.htm#1729391 Filing: 000095017022003292 The citation records this snapshot. The page link may show a newer release later.	−USD 59.54 million Exact value Exact value: -59537000 USD 2020-01-01 – 2020-12-31: -59537000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GALERA THERAPEUTICS, INC. · 2020-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Operating Cash Flow: -59537000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -59537000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017022003292/grtx-20211231.htm#1868763 Filing: 000095017022003292 The citation records this snapshot. The page link may show a newer release later.	USD 457,000 Exact value Exact value: 457000 USD 2020-01-01 – 2020-12-31: 457000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GALERA THERAPEUTICS, INC. · 2020-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Capital Expenditure: 457000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 457000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017022003292/grtx-20211231.htm#1884573 Filing: 000095017022003292 The citation records this snapshot. The page link may show a newer release later.	−USD 59.99 million Calculation and evidence -59537000 − 457000 USD Exact free cash flow: -59994000 USD 2020-01-01 – 2020-12-31: -59537000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 457000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GALERA THERAPEUTICS, INC. · 2020-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Free cash flow: -59994000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -59537000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017022003292/grtx-20211231.htm#1868763 Filing: 000095017022003292 Input fundies:CapitalExpenditure: 457000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017022003292/grtx-20211231.htm#1884573 Filing: 000095017022003292 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 80.53 million Exact value Exact value: -80534000 USD 2021-01-01 – 2021-12-31: -80534000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GALERA THERAPEUTICS, INC. · 2021-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Net Income: -80534000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -80534000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017023006588/grtx-20221231.htm#1943758 Filing: 000095017023006588 The citation records this snapshot. The page link may show a newer release later.	−USD 67.96 million Exact value Exact value: -67958000 USD 2021-01-01 – 2021-12-31: -67958000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GALERA THERAPEUTICS, INC. · 2021-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Operating Cash Flow: -67958000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -67958000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017023006588/grtx-20221231.htm#2102167 Filing: 000095017023006588 The citation records this snapshot. The page link may show a newer release later.	USD 283,000 Exact value Exact value: 283000 USD 2021-01-01 – 2021-12-31: 283000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GALERA THERAPEUTICS, INC. · 2021-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Capital Expenditure: 283000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 283000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017023006588/grtx-20221231.htm#2119603 Filing: 000095017023006588 The citation records this snapshot. The page link may show a newer release later.	−USD 68.24 million Calculation and evidence -67958000 − 283000 USD Exact free cash flow: -68241000 USD 2021-01-01 – 2021-12-31: -67958000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 283000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GALERA THERAPEUTICS, INC. · 2021-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Free cash flow: -68241000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -67958000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017023006588/grtx-20221231.htm#2102167 Filing: 000095017023006588 Input fundies:CapitalExpenditure: 283000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017023006588/grtx-20221231.htm#2119603 Filing: 000095017023006588 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 62.22 million Exact value Exact value: -62222000 USD 2022-01-01 – 2022-12-31: -62222000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GALERA THERAPEUTICS, INC. · 2022-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Net Income: -62222000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -62222000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017024037614/grtx-20231231.htm#973812 Filing: 000095017024037614 The citation records this snapshot. The page link may show a newer release later.	−USD 43.43 million Exact value Exact value: -43426000 USD 2022-01-01 – 2022-12-31: -43426000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GALERA THERAPEUTICS, INC. · 2022-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Operating Cash Flow: -43426000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -43426000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017024037614/grtx-20231231.htm#1089326 Filing: 000095017024037614 The citation records this snapshot. The page link may show a newer release later.	USD 25,000 Exact value Exact value: 25000 USD 2022-01-01 – 2022-12-31: 25000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GALERA THERAPEUTICS, INC. · 2022-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Capital Expenditure: 25000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 25000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017024037614/grtx-20231231.htm#1100015 Filing: 000095017024037614 The citation records this snapshot. The page link may show a newer release later.	−USD 43.45 million Calculation and evidence -43426000 − 25000 USD Exact free cash flow: -43451000 USD 2022-01-01 – 2022-12-31: -43426000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 25000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GALERA THERAPEUTICS, INC. · 2022-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Free cash flow: -43451000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -43426000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017024037614/grtx-20231231.htm#1089326 Filing: 000095017024037614 Input fundies:CapitalExpenditure: 25000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017024037614/grtx-20231231.htm#1100015 Filing: 000095017024037614 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 59.08 million Exact value Exact value: -59082000 USD 2023-01-01 – 2023-12-31: -59082000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GALERA THERAPEUTICS, INC. · 2023-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Net Income: -59082000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -59082000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017025047798/grtx-20241231.htm#1643897 Filing: 000095017025047798 The citation records this snapshot. The page link may show a newer release later.	−USD 44.85 million Exact value Exact value: -44848000 USD 2023-01-01 – 2023-12-31: -44848000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GALERA THERAPEUTICS, INC. · 2023-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Operating Cash Flow: -44848000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -44848000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017025047798/grtx-20241231.htm#1459671 Filing: 000095017025047798 The citation records this snapshot. The page link may show a newer release later.	USD 59,000 Exact value Exact value: 59000 USD 2023-01-01 – 2023-12-31: 59000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GALERA THERAPEUTICS, INC. · 2023-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Capital Expenditure: 59000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 59000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017025047798/grtx-20241231.htm#1476365 Filing: 000095017025047798 The citation records this snapshot. The page link may show a newer release later.	−USD 44.91 million Calculation and evidence -44848000 − 59000 USD Exact free cash flow: -44907000 USD 2023-01-01 – 2023-12-31: -44848000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 59000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GALERA THERAPEUTICS, INC. · 2023-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Free cash flow: -44907000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -44848000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017025047798/grtx-20241231.htm#1459671 Filing: 000095017025047798 Input fundies:CapitalExpenditure: 59000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017025047798/grtx-20241231.htm#1476365 Filing: 000095017025047798 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 18.96 million Exact value Exact value: -18957000 USD 2024-01-01 – 2024-12-31: -18957000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GALERA THERAPEUTICS, INC. · 2024-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Net Income: -18957000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -18957000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156357726000005/grtx-20251231.htm#1488169 Filing: 000156357726000005 The citation records this snapshot. The page link may show a newer release later.	−USD 12.15 million Exact value Exact value: -12145000 USD 2024-01-01 – 2024-12-31: -12145000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GALERA THERAPEUTICS, INC. · 2024-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Operating Cash Flow: -12145000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -12145000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156357726000005/grtx-20251231.htm#1327794 Filing: 000156357726000005 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2024-01-01 – 2024-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GALERA THERAPEUTICS, INC. · 2024-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017025047798/grtx-20241231.htm#1474727 Filing: 000095017025047798 The citation records this snapshot. The page link may show a newer release later.	−USD 12.15 million Calculation and evidence -12145000 − 0 USD Exact free cash flow: -12145000 USD 2024-01-01 – 2024-12-31: -12145000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GALERA THERAPEUTICS, INC. · 2024-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Free cash flow: -12145000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -12145000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156357726000005/grtx-20251231.htm#1327794 Filing: 000156357726000005 Input fundies:CapitalExpenditure: 0 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000095017025047798/grtx-20241231.htm#1474727 Filing: 000095017025047798 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	USD 149.05 million Exact value Exact value: 149049000 USD 2025-01-01 – 2025-12-31: 149049000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GALERA THERAPEUTICS, INC. · 2025-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Net Income: 149049000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 149049000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156357726000005/grtx-20251231.htm#1486317 Filing: 000156357726000005 The citation records this snapshot. The page link may show a newer release later.	−USD 6.05 million Exact value Exact value: -6049000 USD 2025-01-01 – 2025-12-31: -6049000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GALERA THERAPEUTICS, INC. · 2025-12-31 GALERA THERAPEUTICS, INC. (edgar:1563577) Operating Cash Flow: -6049000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T11:15:21Z Snapshot: 8c7b72ef2e453e3cded62fd91c278ebeb5c9b144a53e5a02007330b023b389e6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1563577/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -6049000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1563577/000156357726000005/grtx-20251231.htm#1325911 Filing: 000156357726000005 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

34 filings · 1,573 latest values · 1,573 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001563577, 1563577, GRTX, edgar:1563577

Also known as GALERA THERAPEUTICS, INC., Galera Therapeutics, Inc.

GALERA THERAPEUTICS, INC.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation